For activity quantification based on planar scintillation camera measurements, photon attenuation is an important factor that needs to be corrected for in a patient- and organ-specific manner. One possibility for obtaining attenuation correction maps is to use X-ray CT scout images. Since the intensity of scout images is in relative numbers, their image values need to be multiplied by a factor to become quantitative and thus useful for attenuation correction. The calibration factor can for our current imaging system be obtained from a scanner system file, but is generally not available. For this purpose, a method based on the patient weight has been developed. Results based on 79 patient scout images show that the calibration factor thus determined correlates well with values that, in this case, are independently specified by the system. The accuracy of attenuation correction factors (ACFs) derived from the scout-based attenuation correction maps is evaluated by comparison to ACFs derived from three-dimensional CT studies. For photon energies of 208, 245, and 364 keV, scout-based ACFs are on average 1.2% and 0.5% from the CT-derived values, using the system-based and the weight-based values of the scout-image calibration factor, respectively. The imprecision is somewhat higher for the weight-based method, due to variability in the delineation of the patient contour used as a part of this method. In conclusion, X-ray scouts are found useful for attenuation correction with a satisfactory accuracy obtained, both using the new, weight-based method, and using the previous, system-based method, for determining the required calibration factor.

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2011.1082DOI Listing

Publication Analysis

Top Keywords

attenuation correction
24
calibration factor
16
correction maps
12
scout images
12
activity quantification
8
based patient
8
acfs derived
8
weight-based method
8
attenuation
7
correction
6

Similar Publications

Objectives: Occupational hearing loss is a significant problem worldwide despite the fact that it can be mitigated by the wearing of hearing protection devices (HPDs). When surveyed, workers frequently report that worsened work performance while wearing HPDs is one reason why they choose not to wear them. However, there have been few studies to supplement these subjective reports with objective measures.

View Article and Find Full Text PDF

Background: (Lour.) Merr. is a plant used in traditional Chinese medicine that reduces hepatotoxicity, relieves kidney discomfort, and has anti-inflammatory and antioxidant properties.

View Article and Find Full Text PDF

Attenuated cardiac autonomic function in patients with long-COVID with impaired orthostatic hemodynamics.

Clin Auton Res

January 2025

Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, GAC70 HRIC Building, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.

Purpose: Long-coronavirus disease (long-COVID) is associated with initial orthostatic hypotension and postural orthostatic tachycardia syndrome. Whether altered autonomic tone underlies these abnormalities is unknown. We compared autonomic function between patients with long-COVID and healthy controls, and within patients with long-COVID with different orthostatic hemodynamic phenotypes.

View Article and Find Full Text PDF

A Sustained H/Fluorouracil-Releasing Suppository for High-efficacy and Low-Toxicity Hydrogenochemotherapy of Colon Cancer.

Adv Healthc Mater

January 2025

Shanghai Key Laboratory of Hydrogen Science & Center of Hydrogen Science, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.

To attenuate the intestinal toxicity of chemotherapeutic drugs from rectal suppositories and enhance their chemotherapeutic outcome is greatly significant, but maintains a challenge. In this work, a new strategy of local synergistic hydrogenochemotherapy is proposed to attenuate side effects and enhance therapeutic efficacy based on the anti-cancer selectivity and normal cells-protecting effect of H, and construct a novel anti-cancer formulation of rectal suppository (5-FU/CSN@FAG) by fatty acid glycerides (FAG) encapsulating 5-fluorouracil (5-FU, a first-line drug for colorectal cancer treatment) and cerium silicide nanoparticles (CSN) with a sustained hydrolytic H release behavior which is synchronous with 5-FU release. The 3-week treatment with the suppository once a day can not only completely eradicate colon tumors without tumor recurrence after suppository administration withdrawal, but also efficiently protect the intestinal tract from chemotherapeutic damage.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!